323 related articles for article (PubMed ID: 33028667)
21. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.
Yeh JM; Hur C; Ward Z; Schrag D; Goldie SJ
Gut; 2016 Apr; 65(4):563-74. PubMed ID: 25779597
[TBL] [Abstract][Full Text] [Related]
22. Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer.
Huang Z; Zhu D; Wu L; He M; Zhou X; Zhang L; Zhang H; Wang W; Zhu J; Cheng W; Chen Y; Fan Y; Qi L; Yin Y; Zhu W; Shu Y; Liu P
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):188-196. PubMed ID: 27756776
[TBL] [Abstract][Full Text] [Related]
23. Usefulness and Limitations of a Serum Screening System to Predict the Risk of Gastric Cancer.
Kishino T; Oyama T; Tomori A; Takahashi A; Shinohara T
Intern Med; 2020 Jun; 59(12):1473-1480. PubMed ID: 32188803
[TBL] [Abstract][Full Text] [Related]
24. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer.
Zhu C; Ren C; Han J; Ding Y; Du J; Dai N; Dai J; Ma H; Hu Z; Shen H; Xu Y; Jin G
Br J Cancer; 2014 Apr; 110(9):2291-9. PubMed ID: 24595006
[TBL] [Abstract][Full Text] [Related]
25. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
[No Abstract] [Full Text] [Related]
26. Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma.
Zheng G; Du L; Yang X; Zhang X; Wang L; Yang Y; Li J; Wang C
Br J Cancer; 2014 Nov; 111(10):1985-92. PubMed ID: 25233400
[TBL] [Abstract][Full Text] [Related]
27. OCaMIR-A Noninvasive, Diagnostic Signature for Early-Stage Ovarian Cancer: A Multi-cohort Retrospective and Prospective Study.
Kandimalla R; Wang W; Yu F; Zhou N; Gao F; Spillman M; Moukova L; Slaby O; Salhia B; Zhou S; Wang X; Goel A
Clin Cancer Res; 2021 Aug; 27(15):4277-4286. PubMed ID: 34035068
[TBL] [Abstract][Full Text] [Related]
28. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
29. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
[TBL] [Abstract][Full Text] [Related]
30. Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer.
Chen C; Chen Q; Zhao Q; Liu M; Guo J
Ann Clin Lab Sci; 2017 May; 47(3):260-263. PubMed ID: 28667025
[TBL] [Abstract][Full Text] [Related]
31. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
[TBL] [Abstract][Full Text] [Related]
32. Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers.
Wang P; Yang D; Zhang H; Wei X; Ma T; Cheng Z; Hong Q; Hu J; Zhuo H; Song Y; Jia C; Jing F; Jin Q; Bai C; Mao H; Zhao J
Clin Lung Cancer; 2015 Jul; 16(4):313-9.e1. PubMed ID: 25639977
[TBL] [Abstract][Full Text] [Related]
33. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
34. Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model.
Xie F; Luo N; Lee HP
World J Gastroenterol; 2008 May; 14(19):3021-7. PubMed ID: 18494053
[TBL] [Abstract][Full Text] [Related]
35. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
[TBL] [Abstract][Full Text] [Related]
36. Multiple cytokine profiling in serum for early detection of gastric cancer.
Li J; Xu L; Run ZC; Feng W; Liu W; Zhang PJ; Li Z
World J Gastroenterol; 2018 Jun; 24(21):2269-2278. PubMed ID: 29881236
[TBL] [Abstract][Full Text] [Related]
37. A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer.
Shin VY; Ng EK; Chan VW; Kwong A; Chu KM
Mol Cancer; 2015 Nov; 14():202. PubMed ID: 26607322
[TBL] [Abstract][Full Text] [Related]
38. Identification and Evaluation of Serum MicroRNA-29 Family for Glioma Screening.
Wu J; Li L; Jiang C
Mol Neurobiol; 2015 Dec; 52(3):1540-1546. PubMed ID: 25367878
[TBL] [Abstract][Full Text] [Related]
39. Performance profile of a FDG-PET cancer screening program for detecting gastric cancer: results from a nationwide Japanese survey.
Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
Jpn J Radiol; 2014 May; 32(5):253-9. PubMed ID: 24562822
[TBL] [Abstract][Full Text] [Related]
40. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]